Literature DB >> 29882734

High-resolution 3D volumetric contrast-enhanced MR angiography with a blood pool agent (ferumoxytol) for diagnostic evaluation of pediatric brain arteriovenous malformations.

Michael Iv1, Omar Choudhri1, Robert L Dodd1, Shreyas S Vasanawala1,2, Marcus T Alley3, Michael Moseley3, Samantha J Holdsworth3, Gerald Grant4, Samuel Cheshier4, Kristen W Yeom2.   

Abstract

OBJECTIVE Patients with brain arteriovenous malformations (AVMs) often require repeat imaging with MRI or MR angiography (MRA), CT angiography (CTA), and digital subtraction angiography (DSA). The ideal imaging modality provides excellent vascular visualization without incurring added risks, such as radiation exposure. The purpose of this study is to evaluate the performance of ferumoxytol-enhanced MRA using a high-resolution 3D volumetric sequence (fe-SPGR) for visualizing and grading pediatric brain AVMs in comparison with CTA and DSA, which is the current imaging gold standard. METHODS In this retrospective cohort study, 21 patients with AVMs evaluated by fe-SPGR, CTA, and DSA between April 2014 and August 2017 were included. Two experienced raters graded AVMs using Spetzler-Martin criteria on all imaging studies. Lesion conspicuity (LC) and diagnostic confidence (DC) were assessed using a 5-point Likert scale, and interrater agreement was determined. The Kruskal-Wallis test was performed to assess the raters' grades and scores of LC and DC, with subsequent post hoc pairwise comparisons to assess for statistically significant differences between pairs of groups at p < 0.05. RESULTS Assigned Spetzler-Martin grades for AVMs on DSA, fe-SPGR, and CTA were not significantly different (p = 0.991). LC and DC scores were higher with fe-SPGR than with CTA (p < 0.05). A significant difference in LC scores was found between CTA and fe-SPGR (p < 0.001) and CTA and DSA (p < 0.001) but not between fe-SPGR and DSA (p = 0.146). A significant difference in DC scores was found among DSA, fe-SPGR, and CTA (p < 0.001) and between all pairs of the groups (p < 0.05). Interrater agreement was good to very good for all image groups (κ = 0.77-1.0, p < 0.001). CONCLUSIONS Fe-SPGR performed robustly in the diagnostic evaluation of brain AVMs, with improved visual depiction of AVMs compared with CTA and comparable Spetzler-Martin grading relative to CTA and DSA.

Entities:  

Keywords:  ASL = arterial spin labeling; AVM = arteriovenous malformation; CE-MRA = contrast-enhanced MRA; CTA = CT angiography; DAP = dose area product; DC = diagnostic confidence; DLP = dose length product; DSA = digital subtraction angiography; LC = lesion conspicuity; MR angiography; MRA = MR angiography; TOF = time of flight; arteriovenous malformation; fMRI = functional MRI; fe-SPGR = ferumoxytol-enhanced spoiled gradient recalled acquisition echo; ferumoxytol; high-resolution MRI; vascular disorders

Mesh:

Substances:

Year:  2018        PMID: 29882734     DOI: 10.3171/2018.3.PEDS17723

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  4 in total

1.  Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains.

Authors:  Ashok Joseph Theruvath; Maryam Aghighi; Michael Iv; Hossein Nejadnik; Jonathan Lavezo; Laura Jean Pisani; Heike Elisabeth Daldrup-Link
Journal:  Nanotheranostics       Date:  2020-06-18

Review 2.  Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle.

Authors:  Yue Huang; Jessica C Hsu; Hyun Koo; David P Cormode
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

3.  Three-Dimensional Iron Oxide Nanoparticle-Based Contrast-Enhanced Magnetic Resonance Imaging for Characterization of Cerebral Arteriogenesis in the Mouse Neocortex.

Authors:  Till de Bortoli; Philipp Boehm-Sturm; Stefan P Koch; Melina Nieminen-Kelhä; Lars Wessels; Susanne Mueller; Giovanna D Ielacqua; Jan Klohs; Peter Vajkoczy; Nils Hecht
Journal:  Front Neurosci       Date:  2021-11-26       Impact factor: 4.677

Review 4.  How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol.

Authors:  Heike E Daldrup-Link; Ashok J Theruvath; Ali Rashidi; Michael Iv; Robbie G Majzner; Sheri L Spunt; Stuart Goodman; Michael Moseley
Journal:  Pediatr Radiol       Date:  2021-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.